Association of chondroadherin with leiomyosarcoma

The leiomyosarcoma (LMS) subtype of uterine sarcoma accounts for 1–2 % of uterine neoplasia cases. The present study aimed to demonstrate that the gene and protein chondroadherin (CHAD) levels may serve as novel biomarkers for predicting prognosis and devising novel treatment models for LMS. A total...

Full description

Bibliographic Details
Main Authors: Sefik Gokce, Dilsad Herkiloglu, Ecmel İsik Kaygusuz, Ozge Cevik, Sarfraz Ahmad
Format: Article
Language:English
Published: Elsevier 2023-04-01
Series:Gynecologic Oncology Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352578923000139
_version_ 1827971430457802752
author Sefik Gokce
Dilsad Herkiloglu
Ecmel İsik Kaygusuz
Ozge Cevik
Sarfraz Ahmad
author_facet Sefik Gokce
Dilsad Herkiloglu
Ecmel İsik Kaygusuz
Ozge Cevik
Sarfraz Ahmad
author_sort Sefik Gokce
collection DOAJ
description The leiomyosarcoma (LMS) subtype of uterine sarcoma accounts for 1–2 % of uterine neoplasia cases. The present study aimed to demonstrate that the gene and protein chondroadherin (CHAD) levels may serve as novel biomarkers for predicting prognosis and devising novel treatment models for LMS. A total of 12 patients diagnosed with LMS and 13 patients diagnosed with myomas were included in the study. The extent of tumour cell necrosis, cellularity and atypia and the mitotic index of each patient with LMS were determined. CHAD gene expression was significantly increased in cancerous tissues compared with that in fibroid tissues (2.17 ± 0.88 vs 3.19 ± 1.61; P = 0.047). The mean CHAD protein expression in tissues was higher in LMS cases but this was not statistically significant (217.38 ± 93.9 vs 177.13 ± 66.67;P = 0.226). Positive significant correlations were obtained between CHAD gene expression and mitotic index (r = 0.476; P = 0.008), tumour size (r = 0.385; P = 0.029) and necrosis (r = 0.455; P = 0.011). Furthermore, there were significant positive correlations between CHAD protein expression levels and tumour size (r = 0.360; P = 0.039) and necrosis (r = 0.377; P = 0.032). The present study was the first to demonstrate the significance of CHAD in LMS. The results suggested that, due to its association with LMS, CHAD has predictive value in determining the prognosis of patients with LMS.
first_indexed 2024-04-09T19:08:52Z
format Article
id doaj.art-15d92be7713d48ae9c858cdd8fe7c700
institution Directory Open Access Journal
issn 2352-5789
language English
last_indexed 2024-04-09T19:08:52Z
publishDate 2023-04-01
publisher Elsevier
record_format Article
series Gynecologic Oncology Reports
spelling doaj.art-15d92be7713d48ae9c858cdd8fe7c7002023-04-07T06:50:25ZengElsevierGynecologic Oncology Reports2352-57892023-04-0146101144Association of chondroadherin with leiomyosarcomaSefik Gokce0Dilsad Herkiloglu1Ecmel İsik Kaygusuz2Ozge Cevik3Sarfraz Ahmad4Department of Obstetrics and Gynecology, Yeni Yuzyil University School of Medicine, İstanbul, TurkeyDepartment of Obstetrics and Gynecology, Yeni Yuzyil University School of Medicine, İstanbul, Turkey; Corresponding author at: Department of Obstetrics and Gynecology, Yeni Yuzyil University School of Medicine, no: 51 Cukurcesme St., Istanbul 34245, Turkey.Pathology Department, Zeynep Kamil Training and Research Hospital, İstanbul, TurkeyAydin Adnan Menderes University, School of Medicine, Department of Biochemistry, Aydin, TurkeyAdventHealth Medical Center, Orlando, FL 32804, USAThe leiomyosarcoma (LMS) subtype of uterine sarcoma accounts for 1–2 % of uterine neoplasia cases. The present study aimed to demonstrate that the gene and protein chondroadherin (CHAD) levels may serve as novel biomarkers for predicting prognosis and devising novel treatment models for LMS. A total of 12 patients diagnosed with LMS and 13 patients diagnosed with myomas were included in the study. The extent of tumour cell necrosis, cellularity and atypia and the mitotic index of each patient with LMS were determined. CHAD gene expression was significantly increased in cancerous tissues compared with that in fibroid tissues (2.17 ± 0.88 vs 3.19 ± 1.61; P = 0.047). The mean CHAD protein expression in tissues was higher in LMS cases but this was not statistically significant (217.38 ± 93.9 vs 177.13 ± 66.67;P = 0.226). Positive significant correlations were obtained between CHAD gene expression and mitotic index (r = 0.476; P = 0.008), tumour size (r = 0.385; P = 0.029) and necrosis (r = 0.455; P = 0.011). Furthermore, there were significant positive correlations between CHAD protein expression levels and tumour size (r = 0.360; P = 0.039) and necrosis (r = 0.377; P = 0.032). The present study was the first to demonstrate the significance of CHAD in LMS. The results suggested that, due to its association with LMS, CHAD has predictive value in determining the prognosis of patients with LMS.http://www.sciencedirect.com/science/article/pii/S2352578923000139LeiomyosarcomaChondroadherinMyoma
spellingShingle Sefik Gokce
Dilsad Herkiloglu
Ecmel İsik Kaygusuz
Ozge Cevik
Sarfraz Ahmad
Association of chondroadherin with leiomyosarcoma
Gynecologic Oncology Reports
Leiomyosarcoma
Chondroadherin
Myoma
title Association of chondroadherin with leiomyosarcoma
title_full Association of chondroadherin with leiomyosarcoma
title_fullStr Association of chondroadherin with leiomyosarcoma
title_full_unstemmed Association of chondroadherin with leiomyosarcoma
title_short Association of chondroadherin with leiomyosarcoma
title_sort association of chondroadherin with leiomyosarcoma
topic Leiomyosarcoma
Chondroadherin
Myoma
url http://www.sciencedirect.com/science/article/pii/S2352578923000139
work_keys_str_mv AT sefikgokce associationofchondroadherinwithleiomyosarcoma
AT dilsadherkiloglu associationofchondroadherinwithleiomyosarcoma
AT ecmelisikkaygusuz associationofchondroadherinwithleiomyosarcoma
AT ozgecevik associationofchondroadherinwithleiomyosarcoma
AT sarfrazahmad associationofchondroadherinwithleiomyosarcoma